ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer
| Image |  |
|---|---|
| Description | scientific article published on 02 January 2020 |
| Author/s |
author: Pirjo Laakkonen Marko Salmikangas Mark Barok Heikki Joensuu Vadim Le Joncour |
| Publication date | January 2, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |